The mission of the Technology Transfer Unit at ICMAB is to translate ICMAB research into social use via technology and knowledge transfer, through a process which provides social and economic benefits to ICMAB, Industry and the society.
To date we have filed and licensed a significant number of patents, and we are responsible of advising our researchers in IPR related matters. ICMAB has signed many contracts and collaborations with different types of companies, and, in addition, our researchers contribute by developing new knowledge in collaboration with our industrial partners in many European projects.
Examples: CARBAT, Calcium based rechargeable batteries; MAGBBRIS, New magnetic biomaterials for brain repair and Imaging after Stroke; Smart-4-Fabry, New nanomedicine for the treatment of the Fabry rare disease.
We are approaching a quality improvement of our TT processes, in special for new opportunities marketing of our research results. For this reason, in 2017 we started the project "Review of technology transfer practices at ICMAB: assessing the technology transfer potentials along selected value chains" commissioned by the Fraunhofer- IMW.
We also participated in industrial national projects called “Retos colaboración”, which are led by these companies: Praxis Pharmaceutical, Creaciones Aromáticas Industriales, Oxolutia, Pharma Mar, Almirall,
Industrial stakeholders recognised as key factors in driving innovation, knowledge transfer and competitiveness. They develop research and innovation agendas and roadmaps for action at EU and national level to be supported by both private and public funding. By working effectively together, they also help deliver solutions to major challenges of key concern to citizens such as the ageing society, the environment and food and energy security.
ICMAB participates in the following Technology Platforms:
National Technology Platforms:
European Technology Platforms:
Advanced Materials Cluster (Clúster MAV)
Association with the aim of promoting and contributing to the competitiveness of industries and institutions in the Advanced Materials field in Catalunya. It is formed by 35 industries and institutions.
NANOMOL Technologies S.L., born in UAB Research Park by the end of 2010, co-founded by researchers of NANOMOL research group of ICMAB and CIBER-BBN is a science and innovation driven company providing cutting edge solutions to process, structure and characterize, at micro and nanoscale, active molecules of pharma, biotech and cosmetic companies. Their mission is to generate revolutionary nanomedicines and drug delivery systems with outstanding therapeutic efficacy and patient’s compliance.